Schedule 13G ownership disclosure

Viridian Therapeutics Inc

Security class unavailable · CUSIP: 92790C104

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,114,994
Percent of class
5.2500%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-23-017255
Form type
SC 13G
Filer
VANGUARD GROUP INC
CIK
CIK 102909
Filed
Feb 09, 2023
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub